Optically transparent silk hydrogels

US2016237128A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016237128-A1
Application numberUS-201415025034-A
CountryUS
Kind codeA1
Filing dateSep 26, 2014
Priority dateSep 27, 2013
Publication dateAug 18, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to silk fibroin-based hydrogels, methods for making and using the same.

First claim

Opening claim text (preview).

What is claimed is: 1 . A silk fibroin-based hydrogel, having at least 60% transmittance in a visible spectrum. 2 . The silk fibroin-based hydrogel of claim 1 , having at least 70% transmittance in the visible spectrum. 3 . The silk fibroin-based hydrogel of claim 1 , having at least 75% transmittance in the visible spectrum. 4 . The silk fibroin-based hydrogel of claim 1 , having at least 80% transmittance in the visible spectrum. 5 . The silk fibroin-based hydrogel of claim 1 , having at least 85% transmittance in the visible spectrum. 6 . The silk fibroin-based hydrogel of claim 1 , having at least 90% transmittance in the visible spectrum. 7 . The silk fibroin-based hydrogel of claim 1 , having at least 95% transmittance in the visible spectrum. 8 . The silk fibroin-based hydrogel of any one of claims 1 - 7 , comprising a plurality of crystalized silk fibroin spheres. 9 . The silk fibroin-based hydrogel of claim 8 , wherein the crystalized silk fibroin spheres have an average diameter ranging between about 10 nm and about 150 nm. 10 . The silk fibroin-based hydrogel of any one of claims 1 - 8 , having a compressive modulus ranging between about 2 and about 20 kPa when measured with a crosshead speed of about 2.0 mm/hr. 11 . The silk fibroin-based hydrogel of any one of claims 1 - 9 , wherein the silk fibroin is crosslinked. 12 . The silk fibroin-based hydrogel of claim 11 , wherein the silk fibroin is crosslinked with a crosslinking agent. 13 . The silk fibroin-based hydrogel of claim 12 , wherein the crosslinking agent is an amine-to-amine crosslinker, amine-to-sulfhydryl crosslinker, carboxyl-to-amine crosslinker, photoreactive crosslinker, sulfhydryl-to-carbohydrate crosslinker, sulfhydryl-to-hydroxyl crosslinker, sulfhydryl-to-sulfhydryl crosslinker, or any combination thereof. 14 . The silk fibroin-based hydrogel of claim 12 , wherein the crosslinking agent is EDTA. 15 . The silk fibroin-based hydrogel of any one of claims 1 - 14 , having a porosity of between about 0% and 50%. 16 . The silk fibroin-based hydrogel of any one of claims 1 - 15 , wherein the silk fibroin-based hydrogel comprises silk fibroin polypeptides having an average molecular weight of between about 3.5 kDa and about 350 kDa. 17 . The silk fibroin-based hydrogel of claim 16 , wherein the silk fibroin polypeptides have an average molecular weight of between about 3.5 kDa and about 200 kDa. 18 . The silk fibroin-based hydrogel of claim 16 , wherein the silk fibroin polypeptides have an average molecular weight of between about 3.5 kDa and about 200 kDa. 19 . The silk fibroin-based hydrogel of claim 16 , wherein the silk fibroin polypeptides have an average molecular weight of between about 3.5 kDa and about 120 kDa. 20 . The silk fibroin-based hydrogel of claim 16 , wherein the silk fibroin polypeptides have an average molecular weight of between about 25 kDa and about 200 kDa. 21 . The silk fibroin-based hydrogel of any one of claims 1 - 20 , wherein the silk fibroin-based hydrogel is a three-dimensional (3D) structure, wherein at least one dimension of the 3D structure is at least than 10 micrometer. 22 . The silk fibroin-based hydrogel of claim 21 , wherein the 3D structure comprises a predetermined microstructure fabricated therein. 23 . The silk fibroin-based hydrogel of claim 22 , wherein the predetermined microstructure is a void. 24 . The silk fibroin-based hydrogel of claim 23 , wherein the void is or comprises a hole, a channel, a cavity, or any combination thereof. 25 . A method comprising steps of: providing silk fibroin polypeptides; contacting the silk fibroin polypeptides with an organic solvent so as to induce beta-sheet formation in the silk fibroin polypeptides; flashing off the organic solvent so as to induce formation of the silk fibroin-based hydrogel of any one of claims 1 - 21 . 26 . The method of claim 25 , further comprising a step of crosslinking. 27 . The method of claim 26 , wherein the step of crosslinking is achieved with a crosslinking agent. 28 . The method of claim 27 , wherein the crosslinking agent is EDTA. 29 . The method of any one of claims 25 - 28 , wherein the organic solvent is acetone. 30 . A method comprising steps of: providing the silk fibroin-based hydrogel of any one of claims 1 - 21 ; machining a predetermined microstructure in and/or on the silk fibroin-based hydrogel. 31 . The method of claim 30 , wherein the step of machining is performed with a laser. 32 . A silk fibroin-based hydrogel, comprising: silk fibroin polypeptides that have an average molecular weight in a range of about 3.5 kDa and about; and nanosized crystalline particles are in a range of about 10 nm and about 150 nm, wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 40% and at least 99%. 33 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized as having a compressive modulus in a range between about 2 kPa and about 20 kPa when measured with a crosshead speed of about 0.200 mm/min. 34 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is formed from a silk fibroin solution having a silk fibroin concentration between about 0.1 mg/ML and about 15 mg/ML. 34 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is formed from a silk fibroin solution having a silk fibroing concentration between about 0.1 mg/ML and about 15 mg/ML. 35 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 50% and at least 99%. 36 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 60% and at least 99%. 37 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 70% and at least 99%. 38 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 80% and at least 99%. 39 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 90% and at least 99%. 40 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is characterized by an optical transmittance in the visible spectrum between at least 95% and at least 99%. 41 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel is configured to support incorporation of functional moieties. 42 . The silk fibroin-based hydrogel of claim 41 , wherein the functional moieties are or comprise cells. 43 . The silk fibroin-based hydrogel of claim 42 , wherein the cells are human cornea epithelial cells (HCECs). 44 . The silk fibroin-based hydrogel of claim 32 , wherein the hydrogel degrades rele

Assignees

Inventors

Classifications

  • Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

  • involving non-metallic material, e.g. isolators · CPC title

  • Operations & Transport · mapped topic

  • Cross-linking · CPC title

  • using microcarriers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016237128A1 cover?
The present application relates to silk fibroin-based hydrogels, methods for making and using the same.
Who is the assignee on this patent?
Univ Tufts
What technology area does this patent fall under?
Primary CPC classification C07K14/43586. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).